Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Vascular Delivery of Allogeneic MuStem Cells in Dystrophic Dogs Requires Only Short-Term Immunosuppression to Avoid Host Immunity and Generate Clinical/Tissue Benefits

Abstract : Growing demonstrations of regenerative potential for some stem cells led recently to promising therapeutic proposals for neuromuscular diseases. We have shown that allogeneic MuStem cell transplantation into Golden Retriever muscular dystrophy (GRMD) dogs under continuous immunosuppression (IS) leads to persistent clinical stabilization and muscle repair. However, long-term IS in medical practice is associated with adverse effects raising safety concerns. Here, we investigate whether the IS removal or its restriction to the transplantation period could be considered. Dogs aged 4-5 months old received vascular infusions of allogeneic MuStem cells without IS (GRMD) or under transient IS (GRMD). At 5 months post-infusion, persisting clinical status improvement of the GRMD dogs was observed while GRMD dogs exhibited no benefit. Histologically, only 9-month-old GRMD dogs showed an increased muscle regenerative activity. A mixed cell reaction with the host peripheral blood mononucleated cells (PBMCs) and corresponding donor cells revealed undetectable to weak lymphocyte proliferation in GRMD dogs compared with a significant proliferation in GRMD dogs. Importantly, any dog group showed neither cellular nor humoral anti-dystrophin responses. Our results show that transient IS is necessary and sufficient to sustain allogeneic MuStem cell transplantation benefits and prevent host immunity. These findings provide useful critical insight to designing therapeutic strategies.
Type de document :
Article dans une revue
Liste complète des métadonnées

Littérature citée [85 références]  Voir  Masquer  Télécharger

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01812518
Déposant : Laurent Jonchère <>
Soumis le : lundi 23 juillet 2018 - 10:43:17
Dernière modification le : vendredi 3 juillet 2020 - 11:01:44
Document(s) archivé(s) le : mercredi 24 octobre 2018 - 13:46:19

Fichier

2018 Lorant.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Licence


Distributed under a Creative Commons Paternité - Pas d'utilisation commerciale 4.0 International License

Identifiants

Citation

Judith Lorant, Thibaut Larcher, Nicolas Jaulin, Benoit Hedan, Aurélie Lardenois, et al.. Vascular Delivery of Allogeneic MuStem Cells in Dystrophic Dogs Requires Only Short-Term Immunosuppression to Avoid Host Immunity and Generate Clinical/Tissue Benefits. Cell Transplantation, Cognizant Communication Corporation, 2018, 27 (7), pp.1096-1110. ⟨10.1177/0963689718776306⟩. ⟨hal-01812518⟩

Partager

Métriques

Consultations de la notice

1209

Téléchargements de fichiers

337